In 2024, the global resuscitation devices market was valued at USD 5.06 billion and is projected to grow from USD 5.38 billion in 2025 to USD 9.00 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.6% over the forecast period.
Resuscitation devices, including automated external defibrillators and manual resuscitators, play a critical role in ventilating the lungs and restoring breathing in unconscious individuals. The rising prevalence of obstructive pulmonary disease and cardiovascular disorders, coupled with the increasing number of road accidents, has been driving the global demand for these life-saving devices.
Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/resuscitation-devices-market-109515
Market Trends:
The resuscitation devices market is experiencing significant advancements driven by the increasing prevalence of respiratory and cardiac emergencies. Technological innovations, such as automated resuscitation devices and integrated monitoring systems, are enhancing efficiency and patient outcomes. The growing adoption of portable and user-friendly resuscitation devices in emergency medical services (EMS) is further boosting market demand. Additionally, the rising awareness regarding cardiopulmonary resuscitation (CPR) training programs and government initiatives promoting emergency medical care are contributing to the market's expansion.
List Of Top Resuscitation Devices Market Companies:
· Koninklijke Philips N.V. (Netherlands)
· Hamilton Medical (Switzerland)
· Getinge AB (Sweden)
· Medtronic (Ireland)
· Teleflex Incorporated (U.S.)
· Convatec Group PLC (U.K.)
· Ambu A/S (Denmark)
· Flexicare Medical Limited (U.K.)
· ICU Medical (U.S.)
· ZOLL Medical Corporation (Asahi Kasei) (U.S.)
· Stryker (U.S.)
Market Segmentation:
The resuscitation devices market is segmented based on product type, application, end-user, and region.
Product Type: The resuscitation devices market includes manual resuscitators, automatic resuscitators, ventilators, and airway management devices. Manual resuscitators, such as bag valve masks (BVMs), are widely used in emergency settings due to their affordability and ease of use. Automatic resuscitators are gaining traction in the resuscitation devices market due to their ability to deliver consistent oxygen supply, reducing the risk of human error. The increasing demand for ventilators and airway management devices in hospitals and intensive care units further supports market expansion.
Application: The resuscitation devices market serves various applications, including cardiopulmonary resuscitation (CPR), neonatal care, trauma care, and anesthesia management. CPR applications dominate the resuscitation devices market due to the rising incidence of cardiac arrests globally. Neonatal care is another crucial segment, as premature infants often require resuscitation support for proper breathing. Trauma care applications are also growing, driven by increasing road accidents and emergency response services. The expanding use of resuscitation devices in anesthesia management for surgical procedures further contributes to market growth.
End-User: The resuscitation devices market caters to hospitals, ambulatory surgical centers, emergency medical services (EMS), and home care settings. Hospitals account for the largest share of the resuscitation devices market, given their extensive use of resuscitation equipment in intensive care units and emergency departments. The EMS sector is witnessing rapid growth as paramedics and first responders rely on resuscitation devices for immediate patient care. Ambulatory surgical centers are also increasingly adopting resuscitation devices to enhance patient safety during outpatient procedures. Additionally, the rising demand for home-based resuscitation devices, particularly for chronic respiratory patients, is expanding the market’s reach.
Market Growth:
The resuscitation devices market is expected to grow steadily due to the rising incidence of cardiovascular diseases, respiratory disorders, and sudden cardiac arrests worldwide. The increasing demand for emergency care, along with advancements in healthcare infrastructure, is driving market expansion. Furthermore, the growing geriatric population, which is more susceptible to respiratory failure and cardiac arrests, is a key factor supporting market growth. Continuous improvements in resuscitation technologies, including enhanced oxygen delivery systems and smart monitoring capabilities, are also fueling the market's progress.
Restraining Factors:
Despite its growth potential, the resuscitation devices market faces several challenges. High costs associated with advanced resuscitation devices and the maintenance of critical care equipment limit accessibility, particularly in low-income regions. Additionally, a lack of awareness and inadequate CPR training in developing countries hinder the widespread adoption of resuscitation devices. Stringent regulatory approvals and compliance requirements also pose challenges for manufacturers entering the market. Furthermore, complications arising from improper device usage and mechanical failures can impact patient safety, thereby affecting market growth.
Regional Analysis:
The resuscitation devices market varies across different regions. North America leads the resuscitation devices market, driven by advanced healthcare infrastructure, high adoption of emergency medical technologies, and increased awareness about cardiac and respiratory emergencies. Europe follows closely, with growing investments in healthcare and emergency response systems. The Asia-Pacific region is projected to witness the fastest growth in the resuscitation devices market due to rising healthcare expenditures, an increasing number of emergency cases, and improving access to medical facilities. Meanwhile, Latin America, the Middle East, and Africa are emerging markets where the growing prevalence of respiratory conditions and government efforts to improve healthcare infrastructure are fueling the demand for resuscitation devices.
Key Industry Developments:
In July 2023, Ambu A/S announced that its lung ventilation device, VivaSight 2 SLT, is prepared for commercialization in the European market.
In March 2022, ZOLL Medical Corporation (Asahi Kasei) introduced the Arrhythmia Management System (AMS), which enhances traditional mobile cardiac telemetry (MCT) devices by incorporating biometric data such as heart rate and respiratory rate alongside ECG information